• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·CMR.BK
Share

Chiang Mai Ram Medical Business Public Company Limited Stocks

THB 1.3Last Updated 18.09.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

THB 160.10M

THB 1.3
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Chiang Mai Ram Medical Business Public Company Limited is a Thai healthcare provider primarily operating medical facilities. The company delivers a comprehensive array of medical services, encompassing core specializations such as internal medicine, cardiology, general practice, pediatrics, orthopedics, various surgical fields (general and pediatric), obstetrics-gynecology, radiology, dentistry, anesthesiology, otolaryngology (ENT), and ophthalmology. Beyond these fundamental areas, CMR.BK manages specialized clinics for conditions like urological, neurological, endocrine, oncological, hematological, plastic surgery, gastrointestinal, and dermatological issues, alongside dedicated clinics for infertility and gynecologic oncology. The company further extends its offerings to include a variety of diagnostic and therapeutic services such as dental care, advanced imaging (X-ray, CT colonoscopy), cardiac catheterization, gynecologic cancer treatments, back pain management, physical therapy and rehabilitation, surgical operating theatres, laboratory examinations (including real-time PCR), ambulance services, CRD, and comprehensive health check-ups. Additionally, it provides insurance products. CMR.BK operates its primary medical care center under the name Lanna Hospital. Established in 1974, the company's headquarters are located in Chiang Mai, Thailand. It functions as a subsidiary of Vibhavadi Medical Center Public Company Limited.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, overvalued on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.09.2026 21:00

Anthropic Has Chosen a Stock Exchange; OpenAI Is Aiming for $1.2 Trillion: Key Takeaways on IPOs by September 20

20.09.2026 15:01

Does having a lot of money make an investor more rational? Yes, but only to a certain extent

19.09.2026 16:01

Small-Cap Highlights: Management Shuffle at Hugo Boss, LSD's Success, Yoox Outlet's Surge

19.09.2026 13:01

AI: To Accelerate or Slow Down? Revolut Takes on Extortionists; Luxury Is Becoming More Affordable

19.09.2026 03:54

Trump signed a law imposing sanctions on Russia. It will affect major oil importers.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026